Literature DB >> 24677183

Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.

Yongmei Wang1, Alicia Menendez, Chak Fong, Hashem Z ElAlieh, Wenhan Chang, Daniel D Bikle.   

Abstract

Ephrin B2/EphB4 mediates interactions among osteoblasts (OBs), osteoclasts (OCLs), and chondrocytes to regulate their differentiation. We investigated the role of ephrin B2/EphB4 signaling in mediating the anabolic effects of insulin-like growth factor-I (IGF-I) and parathyroid hormone (PTH) on those cells and overall endochondral bone formation. Immunohistochemistry demonstrated that the expression of ephrin B2 in OBs, OCLs, and osteocytes, and the expression of EphB4 in OBs and osteocytes was dramatically decreased in global IGF-I knockout mice. Inactivation of EphB4 by EphB4 small, interfering RNA (siRNA) in cultured bone marrow stromal cells significantly decreased the mRNA levels of OB differentiation markers and abolished the stimulatory effects of IGF-I on these markers. Blocking the interaction of EphB4 and ephrin B2 in the OB-OCL cocultures with the EphB4 specific peptide TNYL-RAW or deletion of ephrin B2 in OCL prior to coculture led to fewer and smaller tartrate-resistant acid phosphatase (TRAP)-positive cells, decreased expression of OB differentiation markers, and blunted response to IGF-I for both OCL and OB differentiation. In the growth plate, both ephrin B2 and EphB4 are expressed in late stage proliferating and prehypertrophic chondrocytes, and their expression was decreased in mice lacking the IGF-I receptor specifically in chondrocytes. In vitro, blocking the interaction of EphB4 and ephrin B2 in chondrogenic ATDC5 cells with TNYL-RAW significantly decreased both basal and IGF1-induced expression of type II and type X collagen. In the cocultures of ATDC5 cells and spleen cells (osteoclast precursors), TNYL-RAW decreased the numbers of TRAP-positive cells and the expression of nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) and receptor activator of NF-κB (RANK), and blocked their stimulation by IGF-I. Our data indicate that IGF-I/IGF-IR signaling promotes OB, OCL, and chondrocyte differentiation via ephrin B2/EphB4 mediated cell-cell communication.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CELL-CELL COMMUNICATION; CHONDROCYTE; EPHB4; EPHRIN B2; IGF-I

Mesh:

Substances:

Year:  2014        PMID: 24677183      PMCID: PMC4108521          DOI: 10.1002/jbmr.2196

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  45 in total

Review 1.  A novel transgenic mouse model to study the osteoblast lineage in vivo.

Authors:  Christa Maes; Tatsuya Kobayashi; Henry M Kronenberg
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

Review 2.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 3.  Transcriptional control of skeletogenesis.

Authors:  Gerard Karsenty
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

4.  Role of IGF-I signaling in regulating osteoclastogenesis.

Authors:  Yongmei Wang; Shigeki Nishida; Hashem Z Elalieh; Roger K Long; Bernard P Halloran; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

5.  Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.

Authors:  Ritsuko Masuyama; Ingrid Stockmans; Sophie Torrekens; Riet Van Looveren; Christa Maes; Peter Carmeliet; Roger Bouillon; Geert Carmeliet
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

6.  EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.

Authors:  Elizabeth H Allan; Karl D Häusler; Tao Wei; Jonathan H Gooi; Julian M W Quinn; Blessing Crimeen-Irwin; Sueli Pompolo; Natalie A Sims; Matthew T Gillespie; Jude E Onyia; T John Martin
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

7.  Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.

Authors:  Michihiko Usui; Lianping Xing; Hicham Drissi; Michael Zuscik; Regis O'Keefe; Di Chen; Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

Review 8.  Osteoclast-osteoblast communication.

Authors:  Koichi Matsuo; Naoko Irie
Journal:  Arch Biochem Biophys       Date:  2008-03-29       Impact factor: 4.013

9.  IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone.

Authors:  Yongmei Wang; Shigeki Nishida; Benjamin M Boudignon; Andrew Burghardt; Hashem Z Elalieh; Michelle M Hamilton; Sharmila Majumdar; Bernard P Halloran; Thomas L Clemens; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2007-09       Impact factor: 6.741

10.  Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor.

Authors:  C Shukunami; C Shigeno; T Atsumi; K Ishizeki; F Suzuki; Y Hiraki
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  29 in total

1.  Cyclooxygenase-2 deficiency impairs muscle-derived stem cell-mediated bone regeneration via cellular autonomous and non-autonomous mechanisms.

Authors:  Xueqin Gao; Arvydas Usas; Aiping Lu; Adam Kozemchak; Ying Tang; Minakshi Poddar; Xuying Sun; James H Cummins; Johnny Huard
Journal:  Hum Mol Genet       Date:  2016-06-27       Impact factor: 6.150

2.  Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.

Authors:  Kazuaki Miyagawa; Yasuhisa Ohata; Jesus Delgado-Calle; Jumpei Teramachi; Hua Zhou; David D Dempster; Mark A Subler; Jolene J Windle; John M Chirgwin; G David Roodman; Noriyoshi Kurihara
Journal:  JCI Insight       Date:  2020-03-26

3.  Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.

Authors:  Carrie M Nielson; Ching-Ti Liu; Albert V Smith; Cheryl L Ackert-Bicknell; Sjur Reppe; Johanna Jakobsdottir; Christina Wassel; Thomas C Register; Ling Oei; Nerea Alonso; Edwin H Oei; Neeta Parimi; Elizabeth J Samelson; Mike A Nalls; Joseph Zmuda; Thomas Lang; Mary Bouxsein; Jeanne Latourelle; Melina Claussnitzer; Kristin Siggeirsdottir; Priya Srikanth; Erik Lorentzen; Liesbeth Vandenput; Carl Langefeld; Laura Raffield; Greg Terry; Amanda J Cox; Matthew A Allison; Michael H Criqui; Don Bowden; M Arfan Ikram; Dan Mellström; Magnus K Karlsson; John Carr; Matthew Budoff; Caroline Phillips; L Adrienne Cupples; Wen-Chi Chou; Richard H Myers; Stuart H Ralston; Kaare M Gautvik; Peggy M Cawthon; Steven Cummings; David Karasik; Fernando Rivadeneira; Vilmundur Gudnason; Eric S Orwoll; Tamara B Harris; Claes Ohlsson; Douglas P Kiel; Yi-Hsiang Hsu
Journal:  J Bone Miner Res       Date:  2016-09-06       Impact factor: 6.741

Review 4.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

Review 5.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

6.  Genetic mapping of principal components of canine pelvic morphology.

Authors:  Mark J Fealey; Joy Li; Rebel J E Todhunter; Ursula Krotscheck; Kei Hayashi; Marina J McConkey; Adam R Boyko; Jessica J Hayward; Rory J Todhunter
Journal:  Canine Genet Epidemiol       Date:  2017-03-24

7.  Imaging IGF-I uptake in growth plate cartilage using in vivo multiphoton microscopy.

Authors:  Maria A Serrat; Gabriela Ion
Journal:  J Appl Physiol (1985)       Date:  2017-08-10

Review 8.  Targeting the Eph System with Peptides and Peptide Conjugates.

Authors:  Stefan J Riedl; Elena B Pasquale
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 9.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

Review 10.  Role of IGF1 and EFN-EPH signaling in skeletal metabolism.

Authors:  Richard C Lindsey; Charles H Rundle; Subburaman Mohan
Journal:  J Mol Endocrinol       Date:  2018-03-26       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.